ADMP
Adamis Pharmaceuticals Corporation
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
Adamis Pharmaceuticals Corp is a specialty biopharmaceutical company that develops & commercializes products in the therapeutic areas of respiratory disease & allergy. Its products include Epinephrine Injection PFS syringe, APC-1000, APC-2000, & APC-5000.
Market Cap: 135 Million
Primary Exchange: NASDAQ Capital Market
Website: http://www.adamispharmaceuticals.com
Shares Outstanding: 33.4 Million
Float: 25.2 Million
Dividend: 0.0 (0.0%)
Beta: 0.242532
Sector: Healthcare
Industry: Drug Manufacturers
Short Interest (Jan 12, 2018): 2.63 Million
Ethical Flags
Longest drawdown: 1684 trading days
From: 2013-02-12 To: 2019-10-11
Lowest Point:
Adamis: Share Price Continues To Grind Down To A Fine Discount
via: SeekingAlpha at 2019-06-13 04:24:20:000
Adamis Pharmaceuticals ( ADMP ) is a specialty biopharmaceutical company dedicated to developing and commercializing various therapeutic products. The company's leading product, SYMJEPI, is a pre-filled syringe "PFS" device holding 0.3mg or 0.15mg dosage of epinephrine that has FDA approval fo… read more...
Adamis amends U.S. application for higher dose naloxone, hopes for speedy approval
via: SeekingAlpha at 2019-06-11 07:39:43:000
Based on FDA feedback, Adamis Pharmaceuticals ( ADMP -4.5% ) has removed kalo's EVZIO (naloxone HCl injection) 2 mg auto-injector as the Reference Listed Drug (RLD) in its marketing application seeking approval for its higher dose naloxone injection product for the emergency trea… read more...
Adamis amends U.S. application for higher dose naloxone, hopes for speedy approval
via: SeekingAlpha at 2019-06-11 07:39:43:000
Based on FDA feedback, Adamis Pharmaceuticals ( ADMP -4.5% ) has removed kalo's EVZIO (naloxone HCl injection) 2 mg auto-injector as the Reference Listed Drug (RLD) in its marketing application seeking approval for its higher dose naloxone injection product for the emergency trea… read more...
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|---|---|---|---|---|---|
| 2013-12-13 | 17.0 | 1.0 | 17.0 |